Position in JNJ
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$31,492
+$2,893 QoQ
Shares Held
124
+6.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4,620
of 4,664 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Noble Wealth Management PBC holds $799,244 across 11 Drug Manufacturers - General names. JNJ ranks #3 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
603 | $723,256 | |
| 2 | MRK |
Merck & Co., Inc.
|
274 | $35,209 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
124 | $31,492 | |
| 4 | ABBV |
AbbVie Inc.
|
7 | $1,761 | |
| 5 | AZN |
Astrazeneca PLC
|
7 | $1,327 | |
| 6 | NVS |
Novartis AG
|
8 | $1,253 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9 | $1,137 | |
| 8 | AMGN |
Amgen Inc
|
3 | $1,086 |
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,492 | 124 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $28,599 | 117 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $24,213 | 117 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $21,694 | 117 | Shares | Sole | 2026-01-05 | |
| 2025-03-31 | $24,710 | 149 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $22,560 | 156 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||